Genetic biomarker predicted tamoxifen resistance in ER-positive breast cancer

  • July 24, 2014

Loss of function in the deubiquitinase USP9X appears to be associated with resistance to tamoxifen in patients with ER alpha-positive breast cancer, according to study findings.

The results suggest this gene signature may help predict how patients will respond to the drug, researchers wrote.

Full Story »
  • Filter By:

Personalize your page!

Register for Healio to get content tailored to your specialty and areas of interest. It’s FREE and only takes one minute. Register now!

More»
More»
More »
More»